Clinical Trial Update: A Study of Cytisinicline for Smoking Cessation in Adult Smokers [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating cytisinicline for smoking cessation in adult smokers has completed with results posted in November 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Cytisinicline

Snippet

Sponsor: Achieve Life Sciences | Conditions: Smoking Cessation | Phase 3 | Status: COMPLETED | Results posted: 2024-11-14